| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/06/2005 | CN1635911A Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 07/06/2005 | CN1634891A Process for preparation of 6-fluoro-1, 4-dihydro-4-oxo quinoline-3-carboxylic acid derivatives |
| 07/06/2005 | CN1634890A Preparation of sarafloxacin hydrochloride |
| 07/06/2005 | CN1634889A Method for preparing aripiprazole and its intermediate |
| 07/06/2005 | CN1634888A Process for preparing acetyl substituted nitrogen containing heterocyclic compound |
| 07/05/2005 | US6914066 1,2-annelated quinoline derivatives |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 06/30/2005 | WO2005058843A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/30/2005 | WO2005058835A2 Methods of preparing aripiprazole crystalline forms |
| 06/30/2005 | WO2005058834A2 Quinolines useful in treating cardiovascular disease |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143416 Salts and polymorphs of a potent antidiabetic compound |
| 06/30/2005 | US20050143415 For the production of a pharmaceutical agent for therapy of inflammatory diseases |
| 06/30/2005 | CA2550726A1 Methods of preparing aripiprazole crystalline forms |
| 06/30/2005 | CA2548273A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/30/2005 | CA2547518A1 Quinolines useful in treating cardiovascular disease |
| 06/29/2005 | EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546108A1 1,4-substituted cyclohexane derivatives |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1545530A1 Novel crystalline forms of gatifloxacin |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208322C Dihydroindole and tetrahydroquinoline derivatives |
| 06/28/2005 | US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity |
| 06/28/2005 | US6911442 Has no toxicological effects; adapted for oral, topical or parenteral use and may be used for the treatment of bacterial infection in mammals |
| 06/28/2005 | CA2113743C Reinforced rubber article, production thereof and rubber composition suitable therefor |
| 06/23/2005 | WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 06/23/2005 | WO2004052366A9 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/23/2005 | WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 06/23/2005 | US20050137228 Benzyl sulfonamide derivatives |
| 06/23/2005 | US20050137200 Potassium channel modulators; antiarrhythmia agents |
| 06/23/2005 | CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542688A2 1h-imidazo dimers |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | CN1630651A Novel gamma secretase inhibitors |
| 06/22/2005 | CN1630639A Novel pyridine- and quinoline-derivatives |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound |
| 06/22/2005 | CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 06/22/2005 | CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use |
| 06/21/2005 | US6909003 Chemical synthesis of HMG- CoA reductase enzyme inhibitors, anticholesterol agents, by ketalization, reduction, hydrolysis |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908932 Modulators of phosphoinositide 3-kinase |
| 06/16/2005 | WO2005054201A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054183A2 Quinolinone based protein kinase inhibitors |
| 06/16/2005 | WO2005053735A1 Method of removing transition metals, especially from metathesis reaction products |
| 06/16/2005 | WO2005053692A1 Advanced quinolinone based protein kinase inhibitors |
| 06/16/2005 | WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
| 06/16/2005 | WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | WO2005033082A3 Cetp inhibitors and metabolites thereof |
| 06/16/2005 | WO2005033074A3 Salts and polymorphs of a potent antidiabetic compound |
| 06/16/2005 | WO2005028421A8 Process for the synthesis of 6-amino-4-[(3-chloro-4-fluorophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile |
| 06/16/2005 | WO2005007658A3 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 06/16/2005 | US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents |
| 06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 06/16/2005 | US20050131020 N-type calcium channel antagonists for the treatment of pain |
| 06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
| 06/16/2005 | US20050131014 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
| 06/16/2005 | US20050131013 5,7-Dibromo-8-(2-hydroxyethyl) quinoline and 5,7-dibromo-8-(2-methoxycarbonyloxyethyl) quinoline, for treating plant diseases |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130976 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | US20050130966 Sodium channel modulators |
| 06/16/2005 | US20050130943 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
| 06/16/2005 | US20050130852 Lubricating oil composition |
| 06/16/2005 | DE10346940B3 Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate Substituted pentanols, to their use for preparing medicaments especially anti-inflammatory agents as well as pharmaceutical compositions containing them |
| 06/16/2005 | CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | CA2539575A1 Method of removing transition metals, especially from metathesis reaction products |
| 06/15/2005 | EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 06/15/2005 | EP1541149A1 Phosphodiesterase inhibitor |
| 06/15/2005 | EP1539700A1 8-hydroxy quinoline derivatives |
| 06/15/2005 | EP1539699A1 4- 7'-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents |
| 06/15/2005 | EP1539698A1 Method for producing a 3,5-dihydroxy-6-heptenoate |
| 06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
| 06/15/2005 | EP1539163A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 06/15/2005 | EP1539133A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | EP1150973B1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/15/2005 | EP1134219B1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 06/15/2005 | EP1114031B1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/15/2005 | EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 06/15/2005 | CN1628109A Novel aryl- and heteroarylpiperazines |
| 06/15/2005 | CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 06/15/2005 | CN1628093A Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids |
| 06/15/2005 | CN1627945A Quinoline derivatives as NPY antagonists |
| 06/15/2005 | CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 06/15/2005 | CN1626534A Steroid receptor modulator compounds and methods |
| 06/15/2005 | CN1626513A Organometallic complexes and organic electroluminescence device using the same |
| 06/14/2005 | US6906194 Fluorescence assay for kinase activity |